Free Trial
→ Your Wealth is Under Attack (From American Alternative) (Ad) Buy LXEO Stock  Free LXEO Stock Alerts

Lexeo Therapeutics (LXEO) Institutional Ownership

Lexeo Therapeutics logo
$4.12 +0.13 (+3.13%)
As of 02:31 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Lexeo Therapeutics (NASDAQ:LXEO)

Current
Institutional Ownership
Percentage
60.67%
Number of
Institutional Buyers
(last 12 months)
46
Total
Institutional Inflows
(last 12 months)
$68.65M
Number of
Institutional Sellers
(last 12 months)
11
Total
Institutional Outflows
(last 12 months)
$41.15M
Get LXEO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lexeo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

LXEO Institutional Buying and Selling by Quarter

Remove Ads

Lexeo Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/24/2025 Wellington Management Group LLP76,981$507K0.0%+48.3%0.233%
2/18/2025 Frazier Life Sciences Management L.P.955,515$6.29M0.3%-23.6%2.889%
2/17/2025 Woodline Partners LP858,691$5.65M0.0%+0.8%2.597%
2/17/2025 Vestal Point Capital LP1,200,000$7.90M0.5%+41.2%3.629%
2/17/2025 Point72 Asset Management L.P.750,235$4.94M0.0%+102.5%2.269%
2/17/2025 Omega Fund Management LLC1,184,636$7.80M6.5%-49.7%3.582%
2/17/2025 Millennium Management LLC141,951$934K0.0%+282.5%0.429%
2/17/2025 Janus Henderson Group PLC4,339,254$28.51M0.0%+15.3%13.121%
2/17/2025 Deutsche Bank AG13,226$87K0.0%+172.8%0.040%
2/17/2025 DAFNA Capital Management LLC393,083$2.59M0.7%+56.9%1.189%
2/17/2025 Corton Capital Inc.13,771$91K0.1%N/A0.042%
2/17/2025 Bridgeway Capital Management LLC65,000$428K0.0%N/A0.197%
2/17/2025 Bank of America Corp DE30,376$200K0.0%-21.7%0.092%
2/17/2025 BNP Paribas Financial Markets34,527$227K0.0%+523.1%0.104%
2/17/2025 Allostery Investments LP5,054$33K0.0%N/A0.015%
2/14/2025 Jane Street Group LLC14,512$95K0.0%-59.3%0.044%
2/14/2025 Northern Trust Corp214,284$1.41M0.0%+7.1%0.648%
2/14/2025 Boothbay Fund Management LLC147,807$973K0.0%+37.5%0.447%
2/14/2025 D1 Capital Partners L.P.2,203,900$14.50M0.2%-12.1%6.664%
2/14/2025 Adage Capital Partners GP L.L.C.2,209,615$14.54M0.0%-14.9%6.682%
2/14/2025 Price T Rowe Associates Inc. MD10,425$69K0.0%N/A0.032%
2/14/2025 Altium Capital Management LLC405,000$2.67M0.8%N/A1.225%
2/13/2025 Marshall Wace LLP17,794$117K0.0%N/A0.054%
2/13/2025 Jump Financial LLC20,400$134K0.0%N/A0.062%
2/13/2025 Walleye Capital LLC61,930$407K0.0%N/A0.187%
2/13/2025 Barclays PLC55,161$363K0.0%+9.9%0.167%
2/13/2025 ADAR1 Capital Management LLC169,505$1.12M0.2%+196.5%0.513%
2/13/2025 Aristides Capital LLC29,285$193K0.0%N/A0.089%
2/13/2025 Wells Fargo & Company MN11,156$73K0.0%+49.9%0.034%
2/12/2025 Geode Capital Management LLC567,383$3.74M0.0%+2.6%1.716%
2/12/2025 Wellington Management Group LLP76,981$507K0.0%+48.3%0.233%
2/12/2025 JPMorgan Chase & Co.13,371$88K0.0%+30.1%0.040%
2/11/2025 Privium Fund Management B.V.138,115$909K0.2%N/A0.418%
2/4/2025 Bank of New York Mellon Corp50,660$333K0.0%+5.6%0.153%
1/30/2025 Rhumbline Advisers25,197$166K0.0%+19.6%0.076%
1/24/2025 China Universal Asset Management Co. Ltd.7,011$46K0.0%N/A0.021%
1/17/2025 SG Americas Securities LLC10,960$72K0.0%N/A0.033%
12/26/2024 JPMorgan Chase & Co.10,278$93K0.0%+135.6%0.031%
12/13/2024 Exome Asset Management LLC88,148$797K0.5%N/A0.267%
11/19/2024 Barclays PLC50,210$454K0.0%+162.2%0.152%
Crypto’s crashing…but we’re still profiting (Ad)

Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess. The news is screaming fear. But while most traders watch their portfolios tank…

my friend Joel and his team at The Crypto Code are doing the opposite.
11/16/2024 Geode Capital Management LLC553,247$5.00M0.0%+86.5%1.673%
11/15/2024 Frazier Life Sciences Management L.P.1,250,786$11.31M0.5%N/A3.783%
11/15/2024 Barclays PLC50,210$454K0.0%+162.2%0.152%
11/15/2024 Jane Street Group LLC35,677$323K0.0%+33.3%0.108%
11/15/2024 Wellington Management Group LLP51,892$469K0.0%+134.8%0.157%
11/15/2024 State Street Corp253,946$2.30M0.0%+29.4%0.768%
11/15/2024 RA Capital Management L.P.546,554$4.94M0.1%-18.8%1.653%
11/15/2024 Point72 Asset Management L.P.370,407$3.35M0.0%N/A1.120%
11/15/2024 Polar Asset Management Partners Inc.59,800$541K0.0%-8.4%0.181%
11/15/2024 Ikarian Capital LLC257,216$2.33M0.3%N/A0.778%
11/15/2024 Jacobs Levy Equity Management Inc.30,346$274K0.0%N/A0.092%
11/15/2024 Janus Henderson Group PLC3,763,195$34.00M0.0%+18.9%11.383%
11/14/2024 PDT Partners LLC26,608$241K0.0%N/A0.080%
11/14/2024 Braidwell LP728,777$6.59M0.2%-47.3%2.204%
11/14/2024 Eventide Asset Management LLC1,855,986$16.78M0.3%-44.9%5.614%
11/14/2024 Verition Fund Management LLC777,320$7.03M0.0%+84.5%2.351%
11/14/2024 Vestal Point Capital LP850,000$7.68M0.6%+1.2%2.571%
11/14/2024 MetLife Investment Management LLC14,223$129K0.0%+121.5%0.043%
11/13/2024 BNP Paribas Financial Markets5,541$50K0.0%+184.2%0.017%
11/12/2024 Charles Schwab Investment Management Inc.63,874$577K0.0%+107.0%0.193%
10/24/2024 Novo Holdings A S1,122,581$10.15M0.5%-22.6%3.407%
10/23/2024 Values First Advisors Inc.7,446$67K0.0%N/A0.023%
8/20/2024 Novo Holdings A S1,450,500$23.27M1.2%-11.5%4.403%
8/1/2024 Rhumbline Advisers13,357$214K0.0%+37.3%0.041%
7/26/2024 Bank of New York Mellon Corp31,806$510K0.0%+12.3%0.097%
5/17/2024 RA Capital Management L.P.660,938$10.36M0.1%N/A2.006%
5/17/2024 Artal Group S.A.801,716$12.57M0.3%+32.9%2.434%
5/16/2024 Janus Henderson Group PLC2,540,785$39.80M0.0%+9.0%7.713%
5/14/2024 American International Group Inc.5,053$79K0.0%N/A0.015%
5/10/2024 Vanguard Group Inc.481,755$7.55M0.0%+15.8%1.462%
5/1/2024 BNP Paribas Financial Markets4,781$75K0.0%N/A0.015%
4/29/2024Cornell University126,258$1.98M30.0%N/A0.383%
2/20/2024 Eventide Asset Management LLC3,002,831$40.30M0.7%N/A11.268%
2/15/2024 Omega Fund Management LLC2,157,623$28.96M23.5%N/A8.096%
2/15/2024 Blackstone Inc.696,110$9.34M0.0%N/A2.612%
(Data available from 1/1/2016 forward)

Remove Ads

LXEO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LXEO shares?

During the previous two years, 55 institutional investors and hedge funds held shares of Lexeo Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($28.51M), Eventide Asset Management LLC ($16.78M), Adage Capital Partners GP L.L.C. ($14.54M), D1 Capital Partners L.P. ($14.50M), Artal Group S.A. ($12.57M), Novo Holdings A S ($10.15M), and Blackstone Inc. ($9.34M).Learn more on LXEO's institutional investors.

What percentage of Lexeo Therapeutics stock is owned by institutional investors?

60.67% of Lexeo Therapeutics stock is owned by institutional investors. Learn more on LXEO's institutional investor holdings.

Which institutional investors have been buying Lexeo Therapeutics stock?

Of the 49 institutional investors that purchased Lexeo Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Eventide Asset Management LLC ($3.00M), Omega Fund Management LLC ($2.16M), Janus Henderson Group PLC ($1.39M), Frazier Life Sciences Management L.P. ($1.25M), Point72 Asset Management L.P. ($750.24K), Blackstone Inc. ($696.11K), and RA Capital Management L.P. ($660.94K).

How much institutional buying is happening at Lexeo Therapeutics?

Institutional investors have bought a total of 13,227,933 shares in the last 24 months. This purchase volume represents approximately $147.25M in transactions.

Which Lexeo Therapeutics major shareholders have been selling company stock?

Of the 11 institutional investors that sold Lexeo Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Eventide Asset Management LLC ($1.51M), Omega Fund Management LLC ($1.17M), Braidwell LP ($653.70K), Novo Holdings A S ($515.72K), Adage Capital Partners GP L.L.C. ($388.12K), D1 Capital Partners L.P. ($302.71K), and Frazier Life Sciences Management L.P. ($295.27K).

How much institutional selling is happening at Lexeo Therapeutics?

Institutional investors have sold a total of 5,001,181 shares in the last 24 months. This volume of shares sold represents approximately $41.15M in transactions.


Related Companies

This page (NASDAQ:LXEO) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners
A market crash is coming—here’s when
The stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...
Chaikin Analytics | Sponsored
Your Wealth is Under Attack
Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...
American Alternative | Sponsored
A brutally honest economic warning for 2025 (see proof)
New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Ex CIA predicts 40% “double crash” – April 11
The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...
Paradigm Press | Sponsored
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored